Posts by: Joana Carvalho

News, PAH News

Exposure to air pollutants may be linked to disease severity and other clinical outcomes in people with pulmonary arterial hypertension (PAH), a study shows. The study, “Traffic exposures, air ... Read more

June 12, 2019June 12, 2019

FDA Approves Novitium Pharma’s Generic Sildenafil for PAH Treatment

News, PAH News

The U.S. Food and Drug Administration (FDA) has approved Novitium Pharma‘s generic sildenafil for oral suspension at a dose of 10 mg/mL for the treatment of pulmonary arterial hypertension ... Read more

June 5, 2019June 5, 2019

Revatio Reduces Symptoms of PPHTN, Allowing Safe Liver Transplant, Case Report Shows

News, PH News

Treatment with Revatio (sildenafil) successfully reduced symptoms of portopulmonary hypertension (PPHTN), allowing patients to undergo liver transplant safely, a case report study shows. The case report study, “Sildenafil Monotherapy to ... Read more

May 20, 2019June 3, 2019

Resverlogix Announces Promising Findings on Apabetalone, Will Launch Phase 2 Trial in PAH Patients

News, PAH News

Promising preclinical findings recently published in a peer-reviewed journal opened the door to the launch of a Phase 2 trial testing the therapeutic potential of apabetalone (RVX-208), Resverlogix‘s proprietary ... Read more

May 3, 2019May 17, 2019

Beraprost Therapy May Improve Lung and Heart Function in PH Patients, Study Says

News, PH News

Oral beraprost, in combination with standard therapy, may help decrease pulmonary arterial pressure, and improve heart function and exercise capacity in patients with pulmonary hypertension (PH), a study says. The ... Read more

May 2, 2019May 16, 2019

FDA Approves Abbreviated New Drug Application for Cipla’s Ambrisentan Generic Tablets for PAH Treatment

News, PAH News

The U.S. Food and Drug Administration (FDA) has approved the abbreviated new drug application (ANDA) for Cipla‘s ambrisentan generic tablets of 5 and 10 mg. These tablets are a generic ... Read more

April 12, 2019April 12, 2019

Mallinckrodt’s INOmax Approved in Australia for Adults with Perioperative PH and Heart Surgery

News, PH News

The health regulatory agency for Australia has approved Mallinckrodt Pharmaceuticals‘ INOmax (nitric oxide) gas for inhalation as a treatment for adult patients with perioperative pulmonary hypertension (PH) in combination with cardiovascular (heart) ... Read more

April 8, 2019April 18, 2019

Vasodilator Combo Can Treat PH-associated POEMS Syndrome, Report Says

News, PH News

Combined therapy with Revatio (sildenafil) and Opsumit (macitentan) was effective in a patient diagnosed with pulmonary hypertension (PH) associated with a rare blood disorder called polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and ... Read more

March 6, 2019March 12, 2019

Transition from PDE5i to Adempas Without Washout Period Deemed Safe

CTEPH News, News, PAH News, PH News

Transition from phosphodiesterase-5 inhibitors (PDE5i) — such as United Therapeutics’ Adcirca (taladafil) and Pfizer‘s Revatio (sildenafil) — to Bayer‘s Adempas (riociguat), a soluble guanylate cyclase (sGC) stimulator, without a washout period ... Read more

February 28, 2019March 7, 2019

Doctors Urge Early Diagnosis to Save Lives in PH, Other Rare Diseases

News

A group of Canadian doctors highlighted the importance of an early diagnosis among those with rare diseases. The recommendation, released by the Pulmonary Hypertension Association of Canada, came out on Rare ... Read more

Posts by: Joana Carvalho

Joana Carvalho

Exposure to Traffic-Related Air Pollutants Linked to Disease Severity in PAH, UK Study Shows

FDA Approves Novitium Pharma’s Generic Sildenafil for PAH Treatment

Revatio Reduces Symptoms of PPHTN, Allowing Safe Liver Transplant, Case Report Shows

Resverlogix Announces Promising Findings on Apabetalone, Will Launch Phase 2 Trial in PAH Patients

Beraprost Therapy May Improve Lung and Heart Function in PH Patients, Study Says

FDA Approves Abbreviated New Drug Application for Cipla’s Ambrisentan Generic Tablets for PAH Treatment

Mallinckrodt’s INOmax Approved in Australia for Adults with Perioperative PH and Heart Surgery

Vasodilator Combo Can Treat PH-associated POEMS Syndrome, Report Says

Transition from PDE5i to Adempas Without Washout Period Deemed Safe

Doctors Urge Early Diagnosis to Save Lives in PH, Other Rare Diseases

Pin It on Pinterest